4 T1 tumor–bearing mice treated with ttIL-12 + S showed higher proportions of both CD28+CD8+ T cells and NKG2D+CD8+ T cells in lung metastatic nodules than mice treated with wtIL-12 + S or Ctrl+S (Additional file 1: Figure S4). This evidence concerns the gene SPRR2A and neoplasm.